Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26555 | 206 | 23.5 | 47% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1987 | 5071 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INO 2628 CZ | Author keyword | 6 | 100% | 2% | 4 |
2 | DOUBLE PEAKS | Author keyword | 4 | 36% | 4% | 8 |
3 | DISCONTINUOUS ABSORPTION | Author keyword | 1 | 100% | 1% | 2 |
4 | EFFICIENCY OF ENTEROHEPATIC CIRCULATION | Author keyword | 1 | 100% | 1% | 2 |
5 | MNP001 | Author keyword | 1 | 100% | 1% | 2 |
6 | N N DICYCLOPROPYL METHYL PIPERAZINE DICHLORHYDRATE PHARMACOKINETICS | Author keyword | 1 | 100% | 1% | 2 |
7 | TRANSITION AND ELIMINATION PROBABILITIES | Author keyword | 1 | 100% | 1% | 2 |
8 | ENTEROHEPATIC RECIRCULATION | Author keyword | 1 | 16% | 2% | 5 |
9 | ABSORPTION INTERACTION | Author keyword | 1 | 50% | 0% | 1 |
10 | CDRI 85 92 | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AGENT NADOLOL | 9 | 83% | 2% | 5 |
2 | CIMETIDINE ABSORPTION | 4 | 67% | 2% | 4 |
3 | DOUBLE PEAK PHENOMENON | 3 | 24% | 5% | 10 |
4 | BETA BLOCKER PAFENOLOL | 2 | 38% | 2% | 5 |
5 | ELECTROMAGNETIC FLOWMETERS | 2 | 67% | 1% | 2 |
6 | PAFENOLOL | 2 | 50% | 1% | 3 |
7 | CONCENTRATION TIME PROFILE | 1 | 100% | 1% | 2 |
8 | FRACTION ABSORPTION MODELS | 1 | 100% | 1% | 2 |
9 | BLOCKING AGENT NADOLOL | 1 | 33% | 1% | 3 |
10 | DRUGS SUBJECT | 1 | 27% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine | 2003 | 25 | 25 | 60% |
Multiple Peaking Phenomena in Pharmacokinetic Disposition | 2010 | 20 | 199 | 24% |
Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability | 1999 | 6 | 12 | 58% |
Enterohepatic circulation - Physiological, pharmacokinetic and clinical implications | 2002 | 189 | 203 | 5% |
An overview of various validated HPLC and LC-MS/MS methods for quantitation of drugs in bile: challenges and considerations | 2011 | 6 | 34 | 3% |
MODEL IDENTIFICATION AND ESTIMATION OF ORGAN-FUNCTION PARAMETERS USING RADIOACTIVE-TRACERS AND THE IMPULSE-RESPONSE FUNCTION | 1985 | 14 | 28 | 14% |
Methods to evaluate biliary excretion of drugs in humans: An updated review | 2006 | 0 | 133 | 4% |
APPLICATION OF WHOLE-BODY AUTORADIOGRAPHY IN TOXICOLOGY | 1985 | 8 | 38 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHIM THER EUT 1 RUE VAUBENARD | 0 | 25% | 0.5% | 1 |
2 | PHARMACOKINET PHARMACOGENET | 0 | 25% | 0.5% | 1 |
3 | CHIM MINERALE STRUCT | 0 | 17% | 0.5% | 1 |
4 | FOR ENTWICKLUNG BIOPHARM | 0 | 100% | 0.5% | 1 |
5 | INT PHARM BUSINESS | 0 | 100% | 0.5% | 1 |
6 | REGISTRAT DEV DEV KUNDL | 0 | 100% | 0.5% | 1 |
7 | UNITE FORMAT RECH UFR MATH | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000287649 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |
2 | 0.0000183325 | HEIDELBERG CAPSULE//ROXATIDINE ACETATE//SECT PEDIAT CLIN PHARMACOL TOXICOL |
3 | 0.0000139792 | CACO 2//SINGLE PASS INTESTINAL PERFUSION//INTESTINAL PERFUSION |
4 | 0.0000110854 | PROD FORMULAT YODOGAWA KU//CHLORPHENESIN CARBAMATE//DISSOLUTION HEAT |
5 | 0.0000106844 | DISTILLERY VINASSE//MECHANISM EXTR OLAT TECHNOL//RAT INTESTINAL ABSORPTION |
6 | 0.0000105664 | FAMOTIDINE//RANITIDINE HYDROCHLORIDE//NIZATIDINE |
7 | 0.0000104582 | DISSOLUTION TECHNOLOGIES//BIORELEVANT MEDIA//BIOWAIVER |
8 | 0.0000084792 | INTERSPECIES SCALING//DMPK TRANSLAT SCI//WELL STIRRED MODEL |
9 | 0.0000081814 | ESAPRAZOLE//EPOMEDIOL//5 1 2 DIHYDROXY 1 METHYLETHYL 2 METHYL 2 CYCLOHEXEN 1 ONE |
10 | 0.0000080554 | LINOMIDE//ROQUINIMEX//LAQUINIMOD |